THE ROLE OF ENDOTHELIAL DYSFUNCTION IN THE EARLY PREDICTION OF PREECLAMPSIA IN PREGNANT WOMEN WITH IRON DEFICIENCY ANEMIA

Authors

  • Kaypbergenova Gozzal Uralbaevna Department of Obstetrics, Gynecology, and Neonatology, Karakalpakstan Medical Institute Author

Keywords:

Keywords: preeclampsia, iron deficiency anemia, endothelial dysfunction, pregnancy complications, early prediction, oxidative stress, biomarkers, placental angiogenesis.

Abstract

 Preeclampsia remains one of the most severe complications of pregnancy and is a leading cause of maternal and perinatal morbidity and mortality globally. The pathogenesis of this condition is complex and multifaceted, with endothelial dysfunction universally recognized as the central pathophysiological mechanism leading to the clinical manifestations of hypertension and proteinuria. Pregnant women with iron deficiency anemia represent a particularly vulnerable cohort, as chronic tissue hypoxia and elevated oxidative stress inherent to anemia significantly exacerbate vascular endothelial damage. This article investigates the critical role of endothelial dysfunction markers in the early prediction of preeclampsia among pregnant women diagnosed with iron deficiency anemia. A comprehensive prospective cohort study was conducted involving two hundred pregnant women. The participants were evaluated for serum markers of endothelial damage, specifically soluble fms-like tyrosine kinase-1, placental growth factor, endothelin-1, and nitric oxide metabolites, starting from the first trimester. The research demonstrates that the presence of iron deficiency anemia acts as a powerful catalyst for endothelial derangement, leading to an earlier and more pronounced alteration in angiogenic and anti-angiogenic factors. The findings suggest that integrating endothelial dysfunction biomarkers into routine prenatal screening for anemic patients dramatically improves the early predictive accuracy for preeclampsia. This allows for the timely initiation of prophylactic interventions, thereby mitigating the severe clinical outcomes associated with this life-threatening obstetric syndrome. The study underscores the necessity of a systemic approach to maternal health, highlighting the intricate pathophysiological cross-talk between maternal iron status, placental angiogenesis, and systemic vascular integrity.

References

1.Steegers, E. A., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010). Preeclampsia. The Lancet, 376(9741), 631-644.

2.Roberts, J. M., & Hubel, C. A. (2009). The two stage model of preeclampsia. Variations on the theme. Placenta, 30, 32-37.

3.Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010). Two to tango. Regulation of Mammalian iron metabolism. Cell, 142(1), 24-38.

4.Scholl, T. O. (2005). Iron status during pregnancy. Setting the stage for mother and infant. The American Journal of Clinical Nutrition, 81(5), 1218-1222.

5.Hung, T. H., & Burton, G. J. (2006). Hypoxia and reoxygenation. A possible mechanism for placental oxidative stress in preeclampsia. Taiwanese Journal of Obstetrics and Gynecology, 45(3), 189-200.

6.Maynard, S. E., Min, J. Y., Merchan, J., Lim, K. H., Li, J., Mondal, S., & Karumanchi, S. A. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. The Journal of Clinical Investigation, 111(5), 649-658.

7.Granger, J. P., Alexander, B. T., Bennett, W. A., & Khalil, R. A. (2001). Pathophysiology of pregnancy-induced hypertension. American Journal of Hypertension, 14(6), 178-185.

8.Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., & Hund, M. (2016). Predictive value of the sFlt-1 to PlGF ratio in women with suspected preeclampsia. New England Journal of Medicine, 374(1), 13-22.

9.Allen, L. H. (2000). Anemia and iron deficiency. Effects on pregnancy outcome. The American Journal of Clinical Nutrition, 71(5), 1280-1284.

10.Poston, L., Igosheva, N., Mistry, H. D., Seed, P. T., Shennan, A. H., & Rana, S. (2011). Role of oxidative stress and antioxidant supplementation in pregnancy disorders. The American Journal of Clinical Nutrition, 94(6), 1980-1985.

11.Rolnik, D. L., Wright, D., Poon, L. C., O'Gorman, N., Syngelaki, A., de Paco Matallana, C., & Nicolaides, K. H. (2017). Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. New England Journal of Medicine, 377(7), 613-622.

12.Phipps, E. A., Thadhani, R., Benzing, T., & Karumanchi, S. A. (2019). Preeclampsia. Pathogenesis, novel diagnostics and therapies. Nature Reviews Nephrology, 15(5), 275-289.

Downloads

Published

2026-10-27